药品名称ANTURANE
申请号011556产品号004
活性成分SULFINPYRAZONE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构NOVARTIS PHARMACEUTICALS CORP
化学类型New molecular entity (NME)审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
011556053APLetter2002/08/26下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
011556054AP1999/04/22Package Change
011556053AP2002/08/26Labeling Revision
011556052AP1998/09/12Control Supplement
011556051AP1993/01/04Control Supplement
011556050AP1992/10/20Formulation Revision
011556049AP1990/06/13Formulation Revision
011556048AP1987/07/08Formulation Revision
011556047AP1986/09/02Manufacturing Change or Addition
011556046AP1987/03/17Manufacturing Change or Addition
011556045AP1986/04/07Labeling Revision
011556044AP1986/12/08Manufacturing Change or Addition
011556043AP1985/09/30Control Supplement
011556042AP1985/02/27Control Supplement
011556041AP1985/10/08Control Supplement
011556040AP1983/04/09Package Change
011556038AP1984/06/12Labeling Revision
011556037AP1980/02/26Manufacturing Change or Addition
011556036AP1980/10/27Control Supplement
011556035AP1979/09/07Manufacturing Change or Addition
011556034AP1979/07/20Manufacturing Change or Addition
011556033AP1979/07/20Manufacturing Change or Addition
011556032AP1978/08/29Expiration Date Change
011556031AP1978/09/26Control Supplement
011556000AP1959/05/13Approval